| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 04/03/2001 | US6211186 Polyoxyalkylene glycol modified with n-heterocycle derivative with amidine or guanidine group; diaper rash, obesity, acne, periodontal disease, contraceptives; protease and lipase inhibitors |
| 04/03/2001 | US6211182 Histamine h3-antagonists; antiinflammatory agents, antiallergens, antiasthmatics; nervous system, psychological, sleep, and gastrointestinal disorders |
| 03/29/2001 | WO2001021604A1 Substituted piperazine derivatives, the production thereof and their use as inhibitors of the microsomal triglyceride-transfer protein (mtp) |
| 03/29/2001 | WO2001021592A1 Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof |
| 03/29/2001 | WO2001021577A2 Melanin concentrating hormone antagonist |
| 03/29/2001 | DE19945594A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments |
| 03/29/2001 | CA2386474A1 Melanin concentrating hormone antagonist |
| 03/28/2001 | EP1086946A1 Benzamidine derivative |
| 03/28/2001 | EP1086179A1 Energy transfer assay method and reagent |
| 03/28/2001 | EP1086131A1 Cyclic somatostatin analogs |
| 03/28/2001 | EP1086101A1 Beta-carboline compounds |
| 03/28/2001 | EP1086088A2 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 03/28/2001 | EP1086078A1 Neuropeptide y5 receptor antagonists |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085853A1 Heterocyclic ester and amide hair growth compositions and uses |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/28/2001 | EP0767800B1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 03/28/2001 | CN1289324A Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
| 03/28/2001 | CN1289248A Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 03/27/2001 | US6207712 Isolating or synthesizing fatty acid amino acid conjugate selected from n(17-hydroxylinolenoyl)-l-glutamine, n(linolenoyl)-l-glutamine; applying to plant such that plant produces and/or releases volatile compounds |
| 03/27/2001 | US6207708 For therapy and prophylaxis of autoimmune and/or inflammatory conditions affecting the joints such as arthritis, and inflammatory bowel disease, cardivascular ischemia, diabetes, congestive heart failure, myocarditis, atherosclerosis, |
| 03/27/2001 | US6207703 Mucoadministering to airways formulation comprising antifungal agent to reduce or eliminate symptoms of asthma |
| 03/27/2001 | US6207678 Used for treating inflammatory disease such as arthritis, psoriasis, asthma or inflammatory bowel disease, central nervous system disorder such as anxiety, depression, dementia or psychosis, gastrointestinal disorders |
| 03/27/2001 | US6207663 Vitronectin receptor antagonists, their preparation and use |
| 03/27/2001 | US6207363 Cyan ?nb coupler? |
| 03/22/2001 | WO2001019799A2 Nitroimidazole derivative and diagnostic imaging agent containing the same |
| 03/22/2001 | WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/22/2001 | WO2000061134A8 Antimicrobial agents |
| 03/22/2001 | WO2000055155A3 Heterocyclic compounds as adenosine deaminase inhibitors |
| 03/22/2001 | DE19944996A1 Washing agent, useful for the selective desulfurization of gases, is based on an N-substituted nitrogen heterocycle. |
| 03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/21/2001 | EP1084713A1 Preparation of hydrogen peroxide complexes |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083897A1 Hiv integrase inhibitors |
| 03/21/2001 | EP1083894A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 03/21/2001 | CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion |
| 03/20/2001 | US6204406 Catalyst for asymmetric induction |
| 03/20/2001 | US6204391 Water soluble fullerenes with antiviral activity |
| 03/20/2001 | US6204293 Inhibitors of protein isoprenyl transferases |
| 03/15/2001 | WO2001018171A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | WO2001017974A1 Process for preparing a 1-substituted 5-hydroxymethyl imidazole |
| 03/15/2001 | WO2000058286A3 Method of producing heterocyclic carbamates from aza-heterocyclic compounds and carbon dioxide |
| 03/15/2001 | WO2000049007A8 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s |
| 03/15/2001 | DE19943636A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/15/2001 | DE19942961A1 Verfahren zur Herstellung von aromatischen Aminen unter Katalyse von Palladaphosphacyclobutanen A process for the preparation of aromatic amines with catalysis by Palladaphosphacyclobutanen |
| 03/15/2001 | CA2383999A1 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 03/15/2001 | CA2383782A1 Compounds for the treatment of viral infections |
| 03/15/2001 | CA2382861A1 Process for preparing a 1-substituted 5-hydroxymethyl imidazole |
| 03/15/2001 | CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/14/2001 | EP1083163A2 Catalytic method for the preparation of aromatic amines using a palladaphosphacyclobutane compound as catalyst |
| 03/14/2001 | EP1082362A1 Supported group 8-10 transition metal olefin polymerization catalysts |
| 03/14/2001 | EP1082326A1 Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 03/14/2001 | EP1082303A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082280A1 Method for stabilizing unsaturated organic compounds from polymerization |
| 03/14/2001 | EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 03/14/2001 | EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/14/2001 | EP0773782B1 Terpenoidic derivatives (sarcodictyins) useful as antitumor agents |
| 03/14/2001 | CN1063180C 5H, 10H-imidazo [1,2-a] indeno [1,2-e] pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 03/13/2001 | US6201123 Catalyst composition, catalyst solution and process for preparing optically active epoxide |
| 03/13/2001 | US6201024 Effective p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disorders |
| 03/13/2001 | US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction |
| 03/13/2001 | US6201013 Inosine monophosphate dehydrogenase (impdh) inhibitor; side effect reduction, non-drug resistant |
| 03/13/2001 | US6201001 Tubulin polymerization inhibitors; anticarcinogenic agents |
| 03/13/2001 | US6200995 Pyridyloxybenzenesulfonamide derivatives; diabetes, obesity |
| 03/13/2001 | US6200978 For preventing or treating inflammatory diseases such as arthritis, psoriasis, asthma, or inflammatory bowel disease, disorders of respiratory function, gastrointestinal disorders such as functional bowel disease, as analgesics |
| 03/13/2001 | US6200972 Heterocyclic esters and amides |
| 03/13/2001 | US6200938 Amphoteric derivatives of aliphatic polyamines with fatty acids, esters or triglycerides for consumer products and industrial applications |
| 03/13/2001 | US6200925 As polymerization catalyst |
| 03/08/2001 | WO2001016150A2 Nucleoside analogues |
| 03/08/2001 | WO2001016123A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | WO2001016122A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | WO2000059506A8 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | WO1999039704A8 Antibacterial agents |
| 03/08/2001 | WO1999019296A8 Aminobutanoic acid derivatives |
| 03/08/2001 | CA2384194A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | CA2383347A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | CA2382324A1 Nucleoside analogues |
| 03/07/2001 | EP1081146A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081144A2 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081143A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081139A2 Preparation of an imidazolidinedicarboxylic acid |
| 03/07/2001 | EP1081132A1 Hydroxamic acid derivatives and medicinal utilization thereof |
| 03/07/2001 | EP1080077A1 Substituted 1,3-diaza-2-(thi)oxo-cycloalkanes |
| 03/07/2001 | EP1080075A1 Piperididinyl and n-amidinopiperidinyl derivatives |
| 03/07/2001 | EP1079825A2 Compounds that inhibit the binding of integrins to their receptors |
| 03/07/2001 | EP0625969B1 Arylalkoxyphenoxy-imidazoline compounds |
| 03/07/2001 | CN1286251A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286249A Preparation of naphthenic acid |
| 03/06/2001 | US6197995 Process for manufacture of chiral succinic acid derivatives |
| 03/06/2001 | US6197795 Antiarthritic agents; antitumor agents; wound healing agents |